
Join Betsy Pilon, Executive Director at Hope for HIE and Dr. Kenji A. Cunnion, Chief Medical Officer at ReAlta Life Sciences, Inc. for an update on the state of HIE research, the evolution of ReAlta's commitment to therapeutic development for HIE, and the strategy and direction of their upcoming Phase 2 trials.
This episode originally aired 4/28/2022.